BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20380108)

  • 1. ELISA subtypization of anti-ENA autoantibodies in clinical management of autoimmune diseases in Bosnia and Herzegovina.
    Subasic D; Karamehic J; Gavrankapetanovic F; Hodzic H; Kasumovic M; Delic-Sarac M; Prljaca-Zecevic L
    Med Arh; 2009; 63(6):312-6. PubMed ID: 20380108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features].
    Maclachlan D; Vogt P; Wu X; Rose L; Tyndall A; Hasler P
    Z Rheumatol; 2002 Oct; 61(5):534-44. PubMed ID: 12399881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
    Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of autoantibodies to nuclear antigens by EIA and IF techniques.
    Alem M; Moghadam S; Malki J; Zaidi A; Nayak N; Li TM
    Allerg Immunol (Paris); 1997 Sep; 29(7):188, 191-4. PubMed ID: 9373708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies profile in the sera of patients with Sjogren's syndrome: the ANA evaluation--a homogeneous, multiplexed system.
    Gilburd B; Abu-Shakra M; Shoenfeld Y; Giordano A; Bocci EB; delle Monache F; Gerli R
    Clin Dev Immunol; 2004 Mar; 11(1):53-6. PubMed ID: 15154612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay.
    Bremer HD; Lattwein E; Renneker S; Lilliehöök I; Rönnelid J; Hansson-Hamlin H
    Vet Immunol Immunopathol; 2015 Dec; 168(3-4):233-41. PubMed ID: 26547884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing.
    Scholz J; Grossmann K; Knütter I; Hiemann R; Sowa M; Röber N; Rödiger S; Schierack P; Reinhold D; Bogdanos DP; Meroni PL; Radice A; Conrad K; Roggenbuck D
    Clin Chem Lab Med; 2015 Nov; 53(12):1991-2002. PubMed ID: 26020561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of the Contribution of Autoantibodies to Clinical Diagnosis in Liver Pathologies and the Identification of Accompanying Autoimmune Diseases].
    Duran A; Çetin Duran A; Taşkıran İ
    Mikrobiyol Bul; 2022 Jan; 56(1):81-94. PubMed ID: 35088962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of anti-ENA and anti-dsDNA antibodies using line immunoassay in systemic autoimmune diseases].
    Kim JM; Ihm CH; Sin DH; Ihm MK; Sim SC
    Korean J Lab Med; 2008 Oct; 28(5):353-61. PubMed ID: 18971616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens.
    Bentow C; Swart A; Wu J; Seaman A; Manfredi M; Infantino M; Benucci M; Lakos G; Mahler M
    Clin Chim Acta; 2013 Sep; 424():141-7. PubMed ID: 23727029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
    Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
    Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China.
    Yang Z; Ren Y; Liu D; Lin F; Liang Y
    APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical significance of antinuclear antibodies in connective tissue disease.
    Pahor A; Krajnc I; Gorenjak M; Holc I
    Wien Klin Wochenschr; 1998 May; 110(9):338-41. PubMed ID: 9629626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of anti-Sm, anti-RNP, anti-Ro/SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus.
    Sánchez-Guerrero J; Lew RA; Fossel AH; Schur PH
    Arthritis Rheum; 1996 Jun; 39(6):1055-61. PubMed ID: 8651971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population.
    Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM
    Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of antinuclear antibodies (ANA), antibodies to double stranded DNA (anti-dsDNA) and antibodies to extractable nuclear antigens (anti-ENA) in Greek patients.
    Stamouli M; Skliris A; Reppa D; Maganaki E; Totos G
    Clin Lab; 2013; 59(3-4):283-91. PubMed ID: 23724616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of anti-ENA autoantibodies in patients with systemic connective tissue diseases. Analytical variability and diagnostic sensitivity of 4 methods].
    Villalta D; Bizzaro N; Tonutti E; Visentin D; Manoni F; Piazza A; Toffolo L; Rizzotti P; Clemen P; Pradella M; Bassetti D; Tozzoli R
    Recenti Prog Med; 1999 Nov; 90(11):579-84. PubMed ID: 10608146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjögren's syndrome: prevalence and clinical significance in 335 patients.
    Nardi N; Brito-Zerón P; Ramos-Casals M; Aguiló S; Cervera R; Ingelmo M; Font J
    Clin Rheumatol; 2006 May; 25(3):341-6. PubMed ID: 16249826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
    Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
    J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From ANA to ENA: how to proceed?
    Damoiseaux JG; Tervaert JW
    Autoimmun Rev; 2006 Jan; 5(1):10-7. PubMed ID: 16338206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.